Latest From Biotech Now

#BIOCEO14: An Optimistic Outlook for 2014

Panel

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining the current capital market for IPOs, where the industry has been and where it’s headed in 2014. The panel unanimously agreed: 2013 was the year of the IPO. In total, 56 healthcare companies priced an IPO; 43 of these were biotech companies. Last year was the strongest IPO year since 2000 and the second strongest in history with over $10 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Biotechnology Mending Broken Hearts

Biotech-stem-cell-hearts

It’s been just over 15 years since James Thomson first isolated embryonic stem cells in his lab at the University of Wisconsin-Madison. In that time, some remarkable advances have been made. Namely, I’m talking about the ability to transform adult human cells into extremely useful pluripotent stem cells. A new treatment using pluripotent cells could potentially repair and regenerate damaged heart tissue. In a 2013 study published in The Lancet, Dr. Eduardo Marban, director of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Fireside Chat with Allergan CEO, David Pyott

David Pyott

Day two of the 16th Annual BIO CEO & Investor Conference​ kicked off with a Fireside Chat featuring one of the longest tenured pharma CEOs, David E.I. Pyott, Chairman of the Board & Chief Executive Officer, Allergan. The Chat, moderated by Seamus Fernandez, Managing Director, Major and Specialty Pharmaceuticals, Leerink Partners LLC, explored the multi-specialty healthcare model that Allegran has found success in which few realize is not just ophthalmology. Allergan has also found success in neurosciences, medical dermatology, dermal fillers and urologics. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Open Communication Helps Reduce Rare Disease Drug Development Risk

115x76allisonMparks

One of the most important keys to successful relationships – be it in life or rare disease drug development – is open, honest and frequent communication, according to a panel of rare disease experts speaking at the Therapeutic Workshop: “Balancing the Rick-Reward in Rare Disease Drug Development” at the BIO CEO & Investor Conference in New York on Monday. Without engaging the key groups at the right time and the right manner, companies entering this Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Bring Biofortified’s Frank N. Foode™ to Life!

Frank

Biology Fortified (BFI) is launching a Kickstarter fundraising campaign to fund the creation of 500 copies of their blog mascot, Frank N. Foode™. Frank N. Foode™, an adorable plush GM corn, was first handcrafted in 2009 by Karl Haro von Mogel to remind us of the important role that agriculture plays in our everyday lives. This iconic symbol has gotten his photo taken with people, plants, and in exotic places, all to help make the Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , ,